Production (Stage)
Zymeworks Inc.
ZYME
$11.54
$0.060.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 170.29% | 83.33% | -3.07% | 174.82% | -71.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 170.29% | 83.33% | -3.07% | 174.82% | -71.81% |
| Cost of Revenue | 9.15% | 46.93% | 10.92% | -26.00% | -27.90% |
| Gross Profit | 62.01% | 27.32% | -25.10% | 69.39% | -130.93% |
| SG&A Expenses | 7.57% | 9.19% | -18.36% | -27.77% | -6.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.64% | 32.96% | 0.93% | -26.63% | -22.17% |
| Operating Income | 33.48% | 3.91% | -2.91% | 52.69% | -43.76% |
| Income Before Tax | 29.89% | 7.36% | -7.42% | 24.00% | -37.52% |
| Income Tax Expenses | 561.33% | 221.03% | -79.64% | -95.89% | -94.60% |
| Earnings from Continuing Operations | 28.49% | -62.31% | -4.05% | 26.33% | -29.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.49% | -62.31% | -4.05% | 26.33% | -29.98% |
| EBIT | 33.48% | 3.91% | -2.91% | 52.69% | -43.76% |
| EBITDA | 37.36% | 8.11% | -6.72% | 53.99% | -49.84% |
| EPS Basic | 27.50% | -53.94% | 3.54% | 35.12% | -13.81% |
| Normalized Basic EPS | 30.45% | 10.73% | 0.41% | 63.83% | -25.81% |
| EPS Diluted | 27.42% | -53.94% | 4.22% | 35.09% | -12.88% |
| Normalized Diluted EPS | 30.50% | 10.79% | 0.45% | 63.83% | -25.76% |
| Average Basic Shares Outstanding | -1.37% | 5.41% | 7.87% | 13.54% | 14.20% |
| Average Diluted Shares Outstanding | -1.34% | 5.49% | 7.91% | 13.54% | 14.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |